Genmab A/S
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
110 disclosures on record
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 9, 2014 | BlueCrest Capital Management Limited | 0.60% | December 9, 2014 |
| November 6, 2014 | BlueCrest Capital Management Limited | 0.59% | November 6, 2014 |
| October 21, 2014 | BlueCrest Capital Management Limited | 0.60% | October 21, 2014 |
| October 8, 2014 | BlueCrest Capital Management Limited | 0.51% | October 8, 2014 |
| September 17, 2014 | BlueCrest Capital Management Limited | 0.47% | September 17, 2014 |
| September 9, 2014 | BlueCrest Capital Management Limited | 0.57% | September 9, 2014 |
| September 3, 2014 | BlueCrest Capital Management Limited | 0.69% | September 3, 2014 |
| August 21, 2014 | BlueCrest Capital Management Limited | 0.70% | August 21, 2014 |
| August 8, 2014 | BlueCrest Capital Management Limited | 0.60% | August 8, 2014 |
| July 31, 2014 | BlueCrest Capital Management Limited | 0.50% | July 31, 2014 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Genmab A/S, source Finanstilsynet, data as at December 29, 2025, https://www.quivad.com/action/genmab-a-s?page=3